Aberrant endothelial CXCL signaling in COPD

N. Kothapalli (New Haven, CT, United States of America), J. Mcdonough (New Haven, CT, United States of America), M. Raredon (New Haven, CT, United States of America), T. Adams (New Haven, CT, United States of America), J. Schupp (New Haven, CT, United States of America), L. Niklason (New Haven, CT, United States of America), N. Kaminski (New Haven, CT, United States of America), I. Rosas (Houston, TX, United States of America), M. Sauler (New Haven, CT, United States of America)

Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Session: Molecular pathology and cell biology of pulmonary diseases
Session type: E-poster
Number: 3623

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Kothapalli (New Haven, CT, United States of America), J. Mcdonough (New Haven, CT, United States of America), M. Raredon (New Haven, CT, United States of America), T. Adams (New Haven, CT, United States of America), J. Schupp (New Haven, CT, United States of America), L. Niklason (New Haven, CT, United States of America), N. Kaminski (New Haven, CT, United States of America), I. Rosas (Houston, TX, United States of America), M. Sauler (New Haven, CT, United States of America). Aberrant endothelial CXCL signaling in COPD. 3623

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
RAGE-dependent VCAM-1 expression in the pulmonary endothelium mediates IL-33 induced asthma pathogenesis
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017


Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008


T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis
Source: Eur Respir J 2011; 38: 1136-1144
Year: 2011



Interleukin 10 regulates airway remodeling through the TGF-β signaling
Source: Eur Respir J 2005; 26: Suppl. 49, 585s
Year: 2005

Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Rhinovirus uses EGFR signaling to coordinate IL-8 and ICAM-1 expression in bronchial epithelial cells
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008


Expression of amphiregulin regulates airway remodeling
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008

Elevated integrin ?5 expression in idiopathic pulmonary fibrosis (IPF) derived fibroblasts is linked to paracrine TNF-a signaling
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017

Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016

Protease-activated receptor-2 triggers epithelial to mesenchymal transition: Potential relevance in pulmonary fibrosis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Airway epithelial cell IP-10 production is regulated by miR-31 via the transcription factor IRF-1
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015

Increased expression of sphingosine-1-phosphate and S1PR2 are associated with attenuated macrophage phagocytosis in COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015



Transforming Growth factor beta-1 and Smad signaling has the potential to drive EMT-related changes in smokers and COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease
Source: Eur Respir J 2012; 39: 1415-1424
Year: 2012



Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 1137-1149
Year: 2016



Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

Imbalanced expression of the type I TGF-beta receptors ALK-1 in pulmonary fibrosis
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009